Abstract

The Salivary Hormone Profile in the Clinical Evaluation of Women

Author(s): Stephenson Kenna

Issue: Nov/Dec 2004 - Endotoxin

Page(s): 427-435

Download in electronic PDF format for $75
  • The Salivary Hormone Profile in the Clinical Evaluation of Women Page 1
  • The Salivary Hormone Profile in the Clinical Evaluation of Women Page 2
  • The Salivary Hormone Profile in the Clinical Evaluation of Women Page 3
  • The Salivary Hormone Profile in the Clinical Evaluation of Women Page 4
  • The Salivary Hormone Profile in the Clinical Evaluation of Women Page 5
  • The Salivary Hormone Profile in the Clinical Evaluation of Women Page 6
  • The Salivary Hormone Profile in the Clinical Evaluation of Women Page 7
  • The Salivary Hormone Profile in the Clinical Evaluation of Women Page 8
  • The Salivary Hormone Profile in the Clinical Evaluation of Women Page 9

Abstract

Estrogens, progesterone, testosterone, dehydroepiandosterone, and cortisol play vital roles in many aspects of a woman’s physiology and quality of life. A wide variety of symptoms and medical conditions are completely or partially due to elevations or deficiencies of sex hormones in women. Often a clinician suspects that a patient’s symptoms are related to hormone irregularities, but conventional diagnostic serum testing shows hormone levels in the normal ranges. Serum is only one reservoir or sex hormones in the body, and thus serum level does not accurately reflect sex hormone bioavailability. Salivary hormone analysis, on the other hand, offers accurate and comprehensive assessment of hormone bioavailability at the tissue level, from all reservoirs. Reference values for salivary hormone testing have been established for women. Saliva testing is more convenient for the patient and costs less than serum testing, yet it has not been accepted into mainstream medicine. Disadvantages of salivary hormone testing include poor correlation with serum results in women receiving hormone replacement therapy and the potential for contamination of samples. These disadvantages can be overcome with careful sample collection technique and adjusting for the patient’s hormone replacement therapy status. Salivary hormone assay can be adapted by primary care providers to assist in the diagnosis and treatment of conditions related to sex hormone imbalances in women.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2004
Pg. 427-435
Author(s): Stephenson Kenna
Jan/Feb 2001
Pg. 52-54
Author(s): Ford Gina, Garcia Lea
Sep/Oct 2009
Pg. 392-399
Jan/Feb 2004
Pg. 10-14
Author(s): Preckshot John
Jan/Feb 2004
Pg. 16-21
Sep/Oct 2016
Pg. 359-364
Author(s): Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454
Author(s): Deleruyelle Laura J
Sep/Oct 2003
Pg. 330-338
Jul/Aug 2003
Pg. 250-256
Mar/Apr 2008
Pg. 122-127
Mar/Apr 2004
Pg. 96-99
May/Jun 2010
Pg. 193-199
Author(s): Bramwell Bethany L
Jul/Aug 2009
Pg. 280-288
Jan/Feb 2013
Pg. 74-85
View Sample
Jan/Feb 2017
Pg. 6-16
Author(s): Deleruyelle Laura J
Jan/Feb 2015
Pg. 6-12
Mar/Apr 2010
Pg. 165-170
Jul/Aug 2007
Pg. 292-296
Sep/Oct 2001
Pg. 342-344
Author(s): Collins Joseph J
Mar/Apr 2021
Pg. 156-162